Prostate cancer (PCa) is the second most common male cancer and is attributable to over
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …

Abstract The Coronavirus disease 2019 (COVID-19) outbreak has urged the establishment
of a global-wide rapid diagnostic system. Current widely-used tests for COVID-19 include …

In the growing pandemic, family healthcare is widely concerned with the increase of medical
self-diagnosis away from the hospital. A cobalt metal-organic framework modified carbon …

We present a new, power-free and flexible detection system named MCFphone for portable
colorimetric and fluorescence quantitative sandwich immunoassay detection of prostate …

Microfluidic systems enable rapid diagnosis, screening and monitoring of diseases and
health conditions using small amounts of biological samples and reagents. Despite these …

Circulating biomarkers are on the verge of becoming powerful diagnostic tools for various
human diseases. However, the complex sample composition makes it difficult to detect …

The latest clinical procedures for the timely and cost-effective diagnosis of chronic and acute
clinical conditions, such as cardiovascular diseases, cancer, chronic respiratory diseases …

Point-of-care (POC) or near-patient testing allows clinicians to accurately achieve real-time
diagnostic results performed at or near to the patient site. The outlook of POC devices is to …

Monitoring the concentration of a therapeutic drug antibody, infliximab (IFX), is
recommended for enhancing its efficacy in patients with inflammatory bowel disease (IBD) …

A range of biosensing techniques including immunoassays are routinely used for
quantitation of analytes in biological samples and available in a range of formats, from …